NOP2 and nonpapillary renal cell carcinoma: Moreover, altered NOP2 ccRCC samples did not show a better prognosis in progression-free survival, OS, disease-free survival and disease-specific survival, compared with samples without NOP2 alteration, indicating genetic alterations of NOP2 might not play vital roles in ccRCC.